checkAd

     161  0 Kommentare Endo Announces Publication of Phase 3 Qwo (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery - Seite 4

    References:

    1. Hexsel DM, et al. Side-by-side comparison of areas with and without cellulite depressions using magnetic resonance imaging. Dermatol Surg. 2009;35(10):1471-7. 
    2. Khan MH, et al. Treatment of cellulite: Part I. Pathophysiology. J Am Acad Dermatol. 2010;62:361-70.
    3. Querleux B, et al. Anatomy and physiology of subcutaneous adipose tissue by in vivo magnetic resonance imaging and spectroscopy: Relationships with sex and presence of cellulite. Skin Res Technol. 2002;8(2):118-24.
    4. Zhang YZ, et al. Appl Environ Microbiol. 2015;81(18):6098-6107. 
    5. Rossi AM, Katz BE. Dermatol Clin. 2014;32(1):51-59. 
    6. Edkins TJ, et al. Clin Vaccine Immunol. 2012;19(4):562-569. 
    7. Kaplan FT. Drugs Today (Barc). 2011;47(9):653-667.
    8. Rudolph C, et al. Structural gender-dimorphism and the biomechanics of the gluteal subcutaneous tissue – Implications for the pathophysiology of cellulite. Plast Reconstr Surg. 2019;143(4):1077-86.
    9. Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther. 2005;7:1-5.
    10. Pierard GE, et al. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol. 2000;22(1):34-7.

    Logo - https://mma.prnewswire.com/media/530208/Endo_International_plc_Logo.jpg

    Seite 4 von 4




    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Endo Announces Publication of Phase 3 Qwo (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery - Seite 4 DUBLIN, April 13, 2021 /PRNewswire/ - Endo International plc (NASDAQ: ENDP) today announced that Phase 3 data evaluating Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women …